| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Leung Gabriel is a Director at NVCR. Recent filings cover 0 purchases and 52 sales.
Our model assigns Leung Gabriel a strong insider score of 78/100, based on 7 past trades. Over a 12-month horizon, 85.7% of those trades were profitable, with an average 12-month return of +45.4%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | NVCR Novocure Limited | Director | Sell | 2,945 | $15.77 | $46,444.71 | -3.2% | +11.6% | - | |
| Jun 3, 2025 | NVCR Novocure Ltd | Director | Sell | 999 | $17.31 | $17,297.29 | -1.2% | -28.5% | +0.0% | |
| Jun 4, 2024 | NVCR Novocure Ltd | Director | Sell | 964 | $23.89 | $23,025.24 | -1.2% | -26.6% | -26.7% | |
| Aug 5, 2021 | NVCR Novocure Ltd | Director | Sale+OE | 1,000 | $152.50 | $152,500.00 | -1.4% | -29.7% | -51.9% | |
| Jul 6, 2021 | NVCR Novocure Ltd | Director | Sale+OE | 1,000 | $183.54 | $183,540.00 | -1.4% | -41.2% | -60.3% | |
| Jun 7, 2021 | NVCR Novocure Ltd | Director | Sale+OE | 1,000 | $204.55 | $204,550.00 | -1.4% | -33.8% | -62.5% | |
| May 5, 2021 | NVCR Novocure Ltd | Director | Sale+OE | 1,000 | $199.67 | $199,670.00 | -1.4% | -26.1% | -60.2% | |
| Apr 13, 2021 | NVCR Novocure Ltd | Director | Sale+OE | 6,000 | $198.84 | $1,193,035.00 | -7.7% | -2.9% | -56.0% | |
| Sep 15, 2020 | NVCR Novocure Ltd | Director | Sale+OE | 19,565 | $97.44 | $1,906,500.00 | -21.4% | - | - | |
| Sep 10, 2020 | NVCR Novocure Ltd | Director | Sale+OE | 19,114 | $87.80 | $1,678,293.43 | -21.0% | - | - |